Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Benefits and challenges in implementation of artificial intelligence in colonoscopy: World Endoscopy Organization position statement
Hassan, Cesare , Halvorsen, Natalie , Berzin, Tyler M. , Renteln, Daniel von , Hewett, David G. , Repici, Alessandro , Ramchandani, Mohan , Khatry, Maryam Al , Yu, Honggang , Saito, Yutaka , Misawa, Masashi , Parasa, Sravanthi , Matsubayashi, Carolina Ogawa , Ogata, Haruhiko , Tajiri, Hisao, Ahmad, Omer F. , Rex, Douglas K. , Berzin, Tyler M , Hewett, David G , Wang, Pu , Saito, Yutaka , Misawa, Masashi , Matsubayashi, Carolina Ogawa , Hassan, Cesare , Mori, Yuichi , East, James E. , Byrne, Michael F. , Kudo, Shin‐ei , Wang, Pu , Pausawasdi, Nonthalee , Dekker, Evelien , Sharma, Prateek

Mayo Clinic

Digestive Endoscopy | February 7, 2023 | Volume: 35 | Issue: 4 | Pages: 422-429

10.1111/den.14531 | PMID 36749036 Get It

The number of artificial intelligence (AI) tools for colonoscopy on the market is increasing with supporting clinical evidence. Nevertheless, their implementation is not going smoothly for a variety of reasons, including lack of data on clinical benefits and cost‐effectiveness, lack of trustworthy guidelines, uncertain indications, and cost for implementation. To address this issue and better guide practitioners, the World Endoscopy Organization (WEO) has provided its perspective about the status of AI in colonoscopy as the position statement. WEO Position Statement: Statement 1.1: Computer‐aided detection (CADe) for colorectal polyps is likely to improve colonoscopy effectiveness by reducing adenoma miss rates and thus increase adenoma detection; Statement 1.2: In the short term, use of CADe is likely to increase health‐care costs by detecting more adenomas; Statement 1.3: In the long term, the increased cost by CADe could be balanced by savings in costs related to cancer treatment (surgery, chemotherapy, palliative care) due to CADe‐related cancer prevention; Statement 1.4: Health‐care delivery systems and authorities should evaluate the cost‐effectiveness of CADe to support its use in clinical practice; Statement 2.1: Computer‐aided diagnosis (CADx) for diminutive polyps (≤5 mm), when it has sufficient accuracy, is expected to reduce health‐care costs by reducing polypectomies, pathological examinations, or both; Statement 2.2: Health‐care delivery systems and authorities should evaluate the cost‐effectiveness of CADx to support its use in clinical practice; Statement 3: We recommend that a broad range of high‐quality cost‐effectiveness research should be undertaken to understand whether AI implementation benefits populations and societies in different health‐care systems.
QSM Throughout the Body
Dimov, Alexey , Li, Jiahao , Nguyen, Thanh D. , Roberts, Alexandra , Spincemaille, Pascal , Straub, Sina , Zun, Zungho , Prince, Martin R. , Wang, Yi , Dimov, Alexey V , Roberts, Alexandra G , Spincemaille, Pascal , Straub, Sina

Mayo Clinic

Journal of Magnetic Resonance Imaging | February 7, 2023 | Volume: 57 | Issue: 6 | Pages: 1621-1640

10.1002/jmri.28624 | PMID 36748806 Get It

Magnetic materials in tissue, such as iron, calcium, or collagen, can be studied using quantitative susceptibility mapping (QSM). To date, QSM has been overwhelmingly applied in the brain, but is increasingly utilized outside the brain. QSM relies on the effect of tissue magnetic susceptibility sources on the MR signal phase obtained with gradient echo sequence. However, in the body, the chemical shift of fat present within the region of interest contributes to the MR signal phase as well. Therefore, correcting for the chemical shift effect by means of water‐fat separation is essential for body QSM. By employing techniques to compensate for cardiac and respiratory motion artifacts, body QSM has been applied to study liver iron and fibrosis, heart chamber blood and placenta oxygenation, myocardial hemorrhage, atherosclerotic plaque, cartilage, bone, prostate, breast calcification, and kidney stone.
A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia
Wang, Yu‐Hung , Yao, Chi‐Yuan , Lin, Chien‐Chin , Gurashi, Kristian , Amaral, Fabio M. R. , Bossenbroek, Hasse M , Jerez, Andrés , Somervaille, Tim C. P. , Binder, Moritz , Patnaik, Mrinal M. , Chou, Wen‐Chien , Batta, Kiran , Wiseman, Daniel H. , Chou, Wen-Chien , Wiseman, Daniel H , Binder, Moritz , Jerez, Andrés , Wang, Yu-Hung , Somervaille, Tim C.P. , Hou, Hsin‐An , Tien, Hwei‐Fang

Mayo Clinic

British Journal of Haematology | February 7, 2023 | Volume: 201 | Issue: 2 | Pages: 302-307

10.1111/bjh.18681 | PMID 36746431 Get It

SummaryLeukaemic stem cell (LSC) gene expression has recently been linked to prognosis in patients with acute myeloid leukaemia (17‐gene LSC score, LSC‐17) and myelodysplastic syndromes. Although chronic myelomonocytic leukaemia (CMML) is regarded as a stem cell disorder, the clinical and biological impact of LSCs on CMML patients remains elusive. Making use of multiple independent validation cohorts, we here describe a concise three‐gene expression signature (LSC‐3, derived from the LSC‐17 score) as an independent and robust prognostic factor for leukaemia‐free and overall survival in CMML. We propose that LSC‐3 could be used to supplement existing risk stratification systems, to improve prognostic performance and guide management decisions.
Evaluating In-home Assistive Technology for Dementia Caregivers
Levenson, Robert W. , Chen, Kuan‐Hua , Levan, Darius Tran, Chen, Enna Y., Newton, Scott L. , Paul, Deepak, Yee, Claire , Brown, Casey L. , Merrilees, Jennifer , Wang, Gene, Yee, Claire I., Yee, Claire , Levenson, Robert W , Paul, Deepak, Moss, David

Mayo Clinic

Clinical Gerontologist | February 3, 2023 | Volume: 47 | Issue: 1 | Pages: 78-89

10.1080/07317115.2023.2169652 | PMID 36732317 Get It

Management of Anticoagulation/Antiplatelet Medication and Venous Thromboembolism Prophylaxis in Elective Spine Surgery: Concise Clinical Recommendations Based on a Modified Delphi Process
Berven, Sigurd, Streiff, Michael B. , Buchanan, Ian A. , Ha, Alex , Bonfield, Christopher M. , Buchholz, Avery L., Burch, Shane , Devin, Clinton J. , Dimar, John R. , Good, Christopher R. , Lombardi, Joseph M. , Mandigo, Christopher E. , Bydon, Mohamad , Oppenlander, Mark E., Poulter, Gregory T., Shah, Suken A. , Singh, Kern , Than, Khoi D. , Spyropoulos, Alex C. , Kaatz, Scott , Schutzer, Richard, Wang, Tina Z. , Mazique, Derek C., Lenke, Lawrence G. , Lehman, Ronald A. , Zuckerman, Scott L. , Kerolus, Mena G. , Buchowski, Jacob M. , Gum, Jeffrey L. , Kim, Han Jo , Kim, Jun , Polly, David W. , Jain, Amit

Mayo Clinic

Spine | February 2, 2023 | Volume: 48 | Issue: 5 | Pages: 301-309

10.1097/brs.0000000000004540 | PMID 36730667 Get It

Study Design. Delphi method. Objective. To gain consensus on the following questions: (1) When should anticoagulation/antiplatelet (AC/AP) medication be stopped before elective spine surgery?; (2) When should AC/AP medication be restarted after elective spine surgery?; (3) When, how, and in whom should venous thromboembolism (VTE) chemoprophylaxis be started after elective spinal surgery? Summary of Background Data. VTE can lead to significant morbidity after adult spine surgery, yet postoperative VTE prophylaxis practices vary considerably. The management of preoperative AC/AP medication is similarly heterogeneous. Materials and Methods. Delphi method of consensus development consisting of three rounds (January 26, 2021, to June 21, 2021). Results. Twenty-one spine surgeons were invited, and 20 surgeons completed all rounds of questioning. Consensus (>70% agreement) was achieved in 26/27 items. Group consensus stated that preoperative Direct Oral Anticoagulants should be stopped two days before surgery, warfarin stopped five days before surgery, and all remaining AC/AP medication and aspirin should be stopped seven days before surgery. For restarting AC/AP medication postoperatively, consensus was achieved for low-risk/medium-risk/high-risk patients in 5/5 risk factors (VTE history/cardiac/ambulation status/anterior approach/operation). The low/medium/high thresholds were POD7/POD5/POD2, respectively. For VTE chemoprophylaxis, consensus was achieved for low-risk/medium-risk/high-risk patients in 12/13 risk factors (age/BMI/VTE history/cardiac/cancer/hormone therapy/operation/anterior approach/staged separate days/staged same days/operative time/transfusion). The one area that did not gain consensus was same-day staged surgery. The low-threshold/medium-threshold/high-threshold ranges were postoperative day 5 (POD5) or none/POD3-4/POD1-2, respectively. Additional VTE chemoprophylaxis considerations that gained consensus were POD1 defined as the morning after surgery regardless of operating finishing time, enoxaparin as the medication of choice, and standardized, rather than weight-based, dose given once per day. Conclusions. In the first known Delphi study to address anticoagulation/antiplatelet recommendations for elective spine surgery (preoperatively and postoperatively); our Delphi consensus recommendations from 20 spine surgeons achieved consensus on 26/27 items. These results will potentially help standardize the management of preoperative AC/AP medication and VTE chemoprophylaxis after adult elective spine surgery.
Molecular evolution in different subtypes of multifocal hepatocellular carcinoma
Ding, Keyue , Tang, Xia , Li, Qingshu , Shao, Yue, Wan, Li , Zhao, Dachun, Li, Xiaoyuan , Wu, Songfeng , Wang, Haijian , Xiang, Lei, Li, Dewei

Mayo Clinic

No container title available | February 2, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2515298/v1 Get It

Abstract Background: Multifocal hepatocellular carcinoma (MF-HCC) accounts for >40% of HCCs, demonstrating a poor prognosis than single primary HCCs. Characterizing the dynamic changes of mutation signature along with clonal evolution, quantifying intrahepatic metastatic timing, and investigating the genetic structure in the preneoplastic stage underlying different subtypes of MF-HCC are important for understanding their molecular evolution and developing a precision management strategy. Methods: We conducted whole-exome sequencing in 74 tumor samples from spatially distinct regions in 35 resected tumor lesions and adjacent non-cancerous tissues in 11 patients with synchronous MF-HCCs, 15 histologically confirmed preneoplastic lesions and six samples from peripheral blood mononuclear cell. We also used the previously published MF-HCC cohorts (n=9) as an independent validation dataset. Results: We classified MF-HCCs into three subtypes, including intrahepatic metastasis, multicentric occurrence, and mixed intrahepatic metastasis and multicentric occurrence. The dynamic changes in mutation signatures between tumor subclonal expansions demonstrated varied etiologies underlying the clonal progression in different MF-HCC subtypes, especially the contribution of aristolochic acid exposure decreased along with subclonal expansions. The clonal evolution in intrahepatic metastasis exhibited an early metastatic seeding that occurred at 10-4–0.01 cm3 in primary tumor volume, below the limitation in clinical detection. These findings were validated in another independent cohort. In addition, for multicentric occurrence MF-HCC, mutational footprints in the preneoplastic lesions revealed common preneoplastic arising clones, evidently being ancestors of different tumor sites. Conclusion: Our study comprehensively characterized the dynamic mutational signature, early metastatic timing, and common preneoplastic clones in multicentric occurrence that characterized the varied tumor clonal evolutionary history underlying different subtypes of MF-HCC, and provided important implications for optimizing personalized clinical management for MF-HCC.
The Use of Ultrasonic Bone Scalpel (UBS) in Unilateral Biportal Endoscopic Spine Surgery (UBESS): Technical Notes and Outcomes
Tsai, Sung Huang Laurent , Lin, Tung‐Yi , Wang, Ying-Chih , Wong, Chak-Bor, Ghaith, Abdul Karim , Fu, Tsai‐Sheng , Bydon, Mohamad , Lin, Tung-Yi , Wang, Ying-Chih , Ghaith, Abdul Karim , Chang, Chia-Wei , Alvi, Mohammed Ali

Mayo Clinic

Journal of Clinical Medicine | February 2, 2023 | Volume: 12 | Issue: 3 | Pages: 1180

10.3390/jcm12031180 | PMID 36769829 Get It

Study Design: Case Series and Technical Note, Objective: UBS has been extensively used in open surgery. However, the use of UBS during UBESS has not been reported in the literature. The aim of this study was to describe a new spinal surgical technique using an ultrasonic bone scalpel (UBS) during unilateral biportal endoscopic spine surgery (UBESS) and to report the preliminary results of this technique. Methods: We enrolled patients diagnosed with lumbar spinal stenosis who underwent single-level UBESS. All patients were followed up for more than 12 months. A unilateral laminotomy was performed after bilateral decompression under endoscopy. We used the UBS system after direct visualization of the target for a bone cut. We evaluated the demographic characteristics, diagnosis, operative time, and estimated blood loss of the patients. Clinical outcomes included the visual analog scale (VAS), the Oswestry Disability Index (ODI), the modified MacNab criteria, and postoperative complications. Results: A total of twenty patients (five males and fifteen females) were enrolled in this study. The mean follow-up period was 13.2 months (range 12–17 months). The VAS score, ODI, and modified MacNab criteria classification improved after the surgery. A minimal mean blood loss of 22.1 mL was noted during the operation. Only one patient experienced neuropraxia, which resolved within 2 weeks. There was no durotomy, iatrogenic pars fracture, or infection. Conclusions: In conclusion, our study represents the first report of the use of UBS during UBESS. Our findings demonstrate that this technique is safe and efficient, with improved clinical outcomes and minimal complications. These preliminary results warrant further investigation through larger clinical studies with longer follow-up periods to confirm the effectiveness of this technique in the treatment of lumbar spinal stenosis.
Author response: Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14)
Lin, Guang , McGrane, Geoff, Tipon, Regine , Panwala, Leena, Hope, Amanda, Liang, Agnes JH, Zuo, Zhongyuan, Wang, Lily , Tepe, Burak , Croft, Gist F. , Hope, Amanda, Zuo, Zhongyuan , Byeon, Seul Kee , Pandey, Akhilesh , Bellen, Hugo J.

Mayo Clinic

No container title available | January 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.82555.sa2 Get It

P311 Reliability of computed tomography enterography for evaluation of stricturing Crohn’s disease: Development of a Crohn’s disease stricture index
Rieder, F , Baker, Mark E. , Wang, Z, Guizetti, L, Patel, Mona , Niu, Jiafei , Shackelton, L, Ottichilo, Ronald, Santillan, Cynthia , Capozzi, N, Taylor, Stuart A. , Zhou, Guo‐Ping , Bruining, David H. , Feagan, B G, Ma, Christopher , Hanžel, Jurij , Fletcher, Joel G. , Patel, M, Capozzi, Nunzia , Jairath, Vipul , Rimola, Jordi

Mayo Clinic

Journal of Crohn's and Colitis | January 30, 2023 | Volume: 17 | Issue: Supplement_1 | Pages: i453-i453

10.1093/ecco-jcc/jjac190.0441 Get It

Abstract Background Computed tomography enterography (CTE) is frequently used to assess stricturing Crohn’s disease (CD). However, the reliability of CTE items used for assessment has not been established and there is no validated radiologic stricture severity index. Methods We conducted a retrospective study of 43 patients with symptomatic, terminal ileal stricturing CD. Four radiologists assessed a comprehensive list of pre-defined radiologic items potentially associated with stricture severity in 48 CTE scans in two separate rounds in random order. Reliability was quantified using the intraclass correlation coefficient (ICC). Items with at least moderate (ICC≥0.41) inter-rater reliability that were correlated with a visual analogue scale of overall stricture severity were candidate items for the development of a CTE stricture index. Results Inter-rater reliability was almost perfect for assessment of luminal diameter of pre-stenotic dilation (ICC 0.817 [95% confidence interval 0.703, 0.878]), substantial for stricture length (ICC 0.628 [0.419, 0.797]), and moderate for stricture wall thickness (0.482 [0.330, 0.601]). Intra-rater reliability was almost perfect (ICC ≥ 0.850) for all three items. A stricture severity index was derived and was well calibrated (optimism-adjusted calibration slope = 1.009), with scores calculated as the sum of stricture length (cm) + luminal diameter of pre-stenotic dilation (mm) + 5 x stricture wall thickness (mm). Conclusion Stricture length, prestenotic dilation, and stricture wall thickness can be reliably assessed, and are component items for a novel CTE stricture index (CTE-SI) of stricture severity for CD-related terminal ileal strictures. Additional external index validation for clinical and research contexts is required.
Letter: diet‐responsive or just diet‐adherent in EoE. Where is the dietitian? Authors' reply
Wang, Lillian , Alexander, Jeffrey A.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | January 30, 2023 | Volume: 57 | Issue: 4 | Pages: 445-445

10.1111/apt.17350 | PMID 36710541 Get It

LINKED CONTENTThis article is linked to Wang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17221 and https://doi.org/10.1111/apt.17312